LDOS, a government IT toll bridge with a $47B backlog, trading at a 38% discount to intrinsic value
I've been digging into Leidos (LDOS), a $16B defense and government IT contractor. I think the market is overly focused on near-term headwinds and mispricing a highly durable business. Wanted to share my work.
## What they do
Leidos provides the digital and technological backbone for the U.S. government. They don't build tanks. They write the mission software, manage the intelligence analysis, and handle the digital modernization. They also manage health evaluations for the VA. It is essentially a toll bridge for government IT operations. The switching costs are massive. Ripping Leidos out of classified defense networks or air traffic control systems is prohibitively risky.
## Why the stock is cheap
The market is currently fixated on a few localized headaches. There is fear over the upcoming recompete for the Veterans Administration medical disability exam program, coupled with a recent administrative pause on incentive payments. On top of that, their recent $2.4B acquisition of Entrust pushed total debt to $6.58B, making Wall Street nervous about leverage if federal budgets are delayed.
## Why I think the market is wrong
The market is confusing a temporary headache with a structural decline. Despite the VA pause, management actually raised their full-year guidance because the rest of the business is firing on all cylinders. The defense segment booked a massive 2.2x book-to-bill ratio recently. Their backlog sits at $47B, and operating profit margins have structurally expanded from 8.4% to 11.8% over the last five years. The competitive position is strengthening, not weakening.
## Adjusted free cash flow
| Metric | Amount |
|---|---|
| Operating Cash Flow | $2300M |
| Less: Stock-Based Comp | -$21M |
| Less: Maintenance CapEx (5yr avg) | -$164M |
| Less: Working Capital Drain | -$288M |
| **Adjusted Free Cash Flow (FCF)** | **$1798M** |
| FCF Per Share (126.0M shares) | $14.27 |
- ROIC: 12.5% (temporarily depressed by M&A amortization, true incremental returns on capital are over 42%)
- 7-year FCF CAGR: 16.4%
- Maintenance CapEx: <1% of revenue
- Buybacks: $787M TTM
## The balance sheet
| Metric | Amount |
|---|---|
| Liquid Assets | $830M |
| Total Debt | $6578M |
| Market Cap | $16170M |
| **Enterprise Value** | **$21918M** |
| **EV / Adjusted FCF** | **12.2x** |
At 12.2x Adjusted FCF, you are paying a near-record low multiple (the 0th percentile of its 7-year history) for a business that has grown FCF per share at a 16.4% clip.
## Capital allocation
Management acknowledged the low valuation and paused expensive M&A to focus on deleveraging and repurchasing their own undervalued shares. In the trailing twelve months, they bought back $787M in stock while simultaneously paying down $300M of commercial paper tied to the Entrust deal. They are using their asset-light cash flow (CapEx is less than 1% of revenue) to aggressively shrink the share count, reducing it by over 11% since 2020.
## What would make me sell
The debt load is the real risk here. With nearly $5.75B in net debt, there is little room for missteps if cash flows face temporary disruption. If the federal budget process completely breaks down into a prolonged shutdown, or if they lose a massive recompete (like the VA exam contract), the leverage could suddenly become a severe problem. I would sell if operating margins start structurally compressing under competitive pressure.
## Valuation & verdict
I calculated the Owner Earnings and ran the multiple to find the final 38% Margin of Safety. I prefer to talk through the final math rather than typing it all out, so I put my Intrinsic Value calculation and final verdict into a short 5-minute video.
You can see the final numbers here: https://youtu.be/xXzPGhOKzCg?si=-wrwJfNwU8UCBOBN
*Disclosure: I hold a position in $LDOS. Hard data from filings, AI-assisted writing, personal review and position. This is not financial advice.*
